Literature DB >> 30127151

Central retinal vein occlusion revealing celiac disease: The first report of two cases from India.

Ravinder Kaur Malhi1, Abhinav Dhami1, Nirmaljeet Singh Malhi2, Amit Soni2, Gobinder Singh Dhami3.   

Abstract

Entities:  

Keywords:  Anemia; celiac disease; central retinal vein occlusion

Mesh:

Year:  2018        PMID: 30127151      PMCID: PMC6113809          DOI: 10.4103/ijo.IJO_351_18

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.

Case

We report two cases of 35-year and 25-year-old females presented with visual acuity of 6/60 and 5/60 for the right and left eye on Snellen's chart. On evaluation, both eyes showed central retinal vein occlusion (CRVO) [Figs. 1a and b, 2a and b]. The fundus fluorescein angiography showed delayed venous filling and blocked fluorescence with no evidence of neovascularization [Figs. 1e and 2c]. The optical coherence tomography showed cystoid macular edema (CME) [Figs. 1f and 3a]. Investigations for Case 1 revealed marked iron deficiency anemia and thrombocytosis and for Case 2 showed moderate anemia [Table 1]. On physician evaluation, serum antitissue transglutaminase antibody titers were done due to suspicion of celiac disease (CD), which was highly positive. Upper gastrointestinal endoscopy showed scalloping of duodenal folds and loss of villi and thus duodenal biopsy was performed which showed signs of atrophic villi, decreased villous/crypt ratio (<1.1), and cryptic hyperplasia [Figs. 4a and b] graded as Modified Marsh Grade Type 3c,[1] confirming the diagnosis of CD. The patients were managed with gluten-free diet and iron and folate supplementation and each eye underwent intravitreal bevacizumab (1.25 mg/0.5 ml) for the management of CME which showed improvement in vision, resolution of hemorrhages [Figs. 1b–e and 2d–f], and CME [Figs. 1g, 3b and c] over subsequent follow-ups.
Figure 1

(a and b) Posterior pole fundus photograph of right and left eye at initial presentation, (c and d) images of the right eye at subsequent follow-up at 2 monthly intervals after change of diet plan with regard to celiac disease and subsequent clearing of the retinal hemorrhages; (e) the mid arteriovenous phase of fundus fluorescein angiography shows blocked fluorescence due to hemorrhages; (f) the presence of cystoid macular edema at fovea, and (g) the resolution of cystoid macular edema postintravitreal injection of bevacizumab

Figure 2

(a and b) Posterior pole fundus photograph of left and right eye at initial presentation, (c) the mid arteriovenous phase of fundus fluorescein angiography increased optic disc vascularity and increased early and late disc fluorescence with blocked fluorescence due to hemorrhages. (d-f) Images of the left eye at subsequent follow-up at 2 monthly intervals after change of diet plan with regard to celiac disease and subsequent clearing of the retinal hemorrhages

Figure 3

(a) The presence of cystoid macular edema for the second case at initial presentation and (b and c) the subsequent decrease in cystoid macular edema after intravitreal bevacizumab injection

Table 1

The details of investigation for both Case 1 and Case 2

Figure 4

(a) Areas of duodenal erosions with scalloping of duodenal folds and loss of villi, (b) histopathology of duodenal biopsy showing signs of atrophic villi, decreased villous/crypt ratio (<1.1), crypt hyperplasia, increased intraepithelial lymphocytes, and lamina propria showing moderate infiltration with plasma cells, (H and E, ×200)

(a and b) Posterior pole fundus photograph of right and left eye at initial presentation, (c and d) images of the right eye at subsequent follow-up at 2 monthly intervals after change of diet plan with regard to celiac disease and subsequent clearing of the retinal hemorrhages; (e) the mid arteriovenous phase of fundus fluorescein angiography shows blocked fluorescence due to hemorrhages; (f) the presence of cystoid macular edema at fovea, and (g) the resolution of cystoid macular edema postintravitreal injection of bevacizumab (a and b) Posterior pole fundus photograph of left and right eye at initial presentation, (c) the mid arteriovenous phase of fundus fluorescein angiography increased optic disc vascularity and increased early and late disc fluorescence with blocked fluorescence due to hemorrhages. (d-f) Images of the left eye at subsequent follow-up at 2 monthly intervals after change of diet plan with regard to celiac disease and subsequent clearing of the retinal hemorrhages (a) The presence of cystoid macular edema for the second case at initial presentation and (b and c) the subsequent decrease in cystoid macular edema after intravitreal bevacizumab injection The details of investigation for both Case 1 and Case 2 (a) Areas of duodenal erosions with scalloping of duodenal folds and loss of villi, (b) histopathology of duodenal biopsy showing signs of atrophic villi, decreased villous/crypt ratio (<1.1), crypt hyperplasia, increased intraepithelial lymphocytes, and lamina propria showing moderate infiltration with plasma cells, (H and E, ×200)

Discussion

The classic triad of CD: diarrhea, abdominal pain, and malabsorption are seen only in 10%–20% of cases only.[23] In India, most cases of CD are in the northern part of country, as wheat is the staple diet. CD patients have a lifelong risk to develop thrombosis. Reported mechanisms for retinal vein occlusion (RVO) include (a) lack of absorption of Vitamin K, deficiencies of protein C and S, antithrombin, Vitamin B12 and folate, (b) hyperhomocysteinemia, and (c) dehydration and hyperviscosity of blood due to malabsorption and chronic diarrhea.[1]

Conclusion

We recommend inclusion of Anti-Ttg titers in young patients presenting with a RVO, as it is a highly sensitive (74%–94%) and specific test (97%–100%)[1] and can save the patient from life-threatening thrombotic complications.[234]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Nonischemic central retinal vein occlusion associated with celiac disease.

Authors:  Eric S Lee; Jose S Pulido
Journal:  Mayo Clin Proc       Date:  2005-02       Impact factor: 7.616

Review 2.  Ophthalmologic manifestations of celiac disease.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Maria Kiyoko Oyamada; Paulo Schor; Aytan Miranda Sipahi
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

Review 3.  Celiac disease in India.

Authors:  Surender Kumar Yachha; Ujjal Poddar
Journal:  Indian J Gastroenterol       Date:  2007 Sep-Oct

4.  [An atypical presentation of celiac disease: central retinal vein occlusion].

Authors:  Taieb Jomni; Syrine Bellakhal; Maher Abouda; Imene Abdelaali; Hédi Douggui
Journal:  Pan Afr Med J       Date:  2015-11-25
  4 in total
  2 in total

Review 1.  Ocular manifestations in celiac disease: an overview.

Authors:  Fotios S Fousekis; Andreas Katsanos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

Review 2.  Celiac Disease: Extraintestinal Manifestations and Associated Conditions.

Authors:  Amelie Therrien; Ciaran P Kelly; Jocelyn A Silvester
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.